Trials / Suspended
SuspendedNCT03036111
Effect of Topical Trimebutine on Pain After Hemorrhoidectomy
Effect of Trimebutine on Postoperative Pain After Milligan-Morgan Hemorrhoidectomy: A Randomized Controlled Trial
- Status
- Suspended
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Mansoura University · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Trimebutine acts through smooth muscle relaxation. It is presumed that the topical application of trimebutine after hemorrhoidectomy may help relieve pain after the procedure by relaxing the internal anal sphincter spasm.
Detailed description
A randomized trial will be carried out to investigate the effect of trimebutine on pain after Milligan-Morgan hemorrhoidectomy. Trimebutine relaxes the internal anal sphincter spasm which usually occurs after excisional hemorrhoidectomy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Trimebutine | Trimebutine suppository will be inserted in the anal canal on completion of hemorrhoidectomy then at six and 12 hours postoperatively. |
| PROCEDURE | Hemorrhoidectomy | Patients will undergo classic Milliagn-Morgan hemorrhoidectomy |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2018-02-01
- Completion
- 2018-04-01
- First posted
- 2017-01-30
- Last updated
- 2017-08-29
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT03036111. Inclusion in this directory is not an endorsement.